-
公开(公告)号:US20050171188A1
公开(公告)日:2005-08-04
申请号:US11043176
申请日:2005-01-27
申请人: Edmond Differding , Benoit Kenda , Benedicte Lallemand , Alain Matagne , Philippe Michel , Patrick Pasau , Patrice Talaga
发明人: Edmond Differding , Benoit Kenda , Benedicte Lallemand , Alain Matagne , Philippe Michel , Patrick Pasau , Patrice Talaga
IPC分类号: C07D401/04 , A61K31/4015 , A61K31/4025 , A61K31/41 , A61K31/4178 , A61K31/4188 , A61K31/4192 , A61K31/4196 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/4439 , A61K31/497 , A61K31/506 , A61K31/541 , A61P9/00 , A61P9/06 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/00 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P27/16 , A61P37/08 , C07B61/00 , C07C237/06 , C07C237/12 , C07D207/26 , C07D207/27 , C07D207/273 , C07D207/277 , C07D307/33 , C07D401/06 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D495/04 , C07D207/12
CPC分类号: C07D207/26 , A61K31/4015 , C07C237/12 , C07D207/27 , C07D207/273 , C07D207/277 , C07D307/33 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/12 , C07D409/04 , C07D413/04 , C07D417/04 , C07D495/04
摘要: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
-
2.2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses 有权
标题翻译: 2-氧代-1-吡咯烷衍生物,其制备方法及其用途公开(公告)号:US20080097109A1
公开(公告)日:2008-04-24
申请号:US12000512
申请日:2007-12-13
申请人: Edmon Differding , Benoit Kenda , Benedicte Lallemand , Alain Matagne , Philippe Michel , Patrick Pasau , Patrick Talaga
发明人: Edmon Differding , Benoit Kenda , Benedicte Lallemand , Alain Matagne , Philippe Michel , Patrick Pasau , Patrick Talaga
IPC分类号: C07D207/12
CPC分类号: C07D207/26 , A61K31/4015 , C07C237/12 , C07D207/27 , C07D207/273 , C07D207/277 , C07D307/33 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/12 , C07D409/04 , C07D413/04 , C07D417/04 , C07D495/04
摘要: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
摘要翻译: 本发明涉及式I的2-氧代-1-吡咯烷衍生物,其中取代基如说明书中所定义,以及它们作为药物的用途。 本发明的化合物特别适用于治疗诸如癫痫的神经障碍。
-
3.2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses 审中-公开
标题翻译: 2-氧代-1-吡咯烷衍生物,其制备方法及其用途公开(公告)号:US20050171187A1
公开(公告)日:2005-08-04
申请号:US11043145
申请日:2005-01-27
申请人: Edmond Differding , Benoit Kenda , Benedicte Lallemand , Alain Matagne , Philippe Michel , Patrick Pasau , Patrice Talaga
发明人: Edmond Differding , Benoit Kenda , Benedicte Lallemand , Alain Matagne , Philippe Michel , Patrick Pasau , Patrice Talaga
IPC分类号: C07D401/04 , A61K31/4015 , A61K31/4025 , A61K31/41 , A61K31/4178 , A61K31/4188 , A61K31/4192 , A61K31/4196 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/4439 , A61K31/497 , A61K31/506 , A61K31/541 , A61P9/00 , A61P9/06 , A61P9/10 , A61P11/00 , A61P11/06 , A61P21/00 , A61P25/00 , A61P25/04 , A61P25/06 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P27/16 , A61P37/08 , C07B61/00 , C07C237/06 , C07C237/12 , C07D207/26 , C07D207/27 , C07D207/273 , C07D207/277 , C07D307/33 , C07D401/06 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D495/04 , C07D207/12
CPC分类号: C07D207/26 , A61K31/4015 , C07C237/12 , C07D207/27 , C07D207/273 , C07D207/277 , C07D307/33 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/12 , C07D409/04 , C07D413/04 , C07D417/04 , C07D495/04
摘要: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
摘要翻译: 本发明涉及式I的2-氧代-1-吡咯烷衍生物,其中取代基如说明书中所定义,以及它们作为药物的用途。 本发明的化合物特别适用于治疗诸如癫痫的神经障碍。
-
-